Core Viewpoint - The recent election results for the Chinese Academy of Sciences and the Chinese Academy of Engineering highlight a significant focus on cancer research, particularly in liver and gastrointestinal cancers, with notable advancements in prevention and early diagnosis [3][4]. Group 1: New Academicians - A total of 73 new academicians were elected to the Chinese Academy of Sciences, and 71 to the Chinese Academy of Engineering [3]. - Among the newly elected academicians, significant contributions come from experts in clinical medicine, particularly in cancer research [3]. Group 2: Focus on Liver Cancer - The field of liver cancer remains a critical area of research, with approximately 900,000 new cases globally each year, and China accounting for nearly half of these cases [3]. - A major report published in The Lancet by academicians Zhou Jian and Fan Jia indicates that at least 60% of liver cancer cases are preventable through risk factor reduction [4]. Group 3: Innovations in Diagnosis and Treatment - Zhou Jian and Fan Jia have developed a miRNA-based early diagnosis model for liver cancer, which has been successfully transformed into a clinical application, significantly improving early detection rates compared to traditional markers [5]. - The overall survival rate for treated patients has reached an international leading level due to innovative personalized treatment strategies [5]. Group 4: Gastrointestinal Cancer Research - Gastrointestinal cancer also has a high incidence rate in China, with significant contributions from academician Fang Jingyuan in early diagnosis, prevention, and comprehensive treatment strategies [5].

在新当选中国科学院院士的上海医院专家中，周俭致力于肝胆肿瘤临床和基础研究，曾5次获国家科技 进步奖；房静远专注于胃肠癌的防治。至此，中山医院现有包括葛均波、樊嘉、周俭3位中国科学院院 士；而仁济医院也拥有中国工程院院士夏强和中国科学院院士房静远2名院士。 从此次新增院士名单来看，肿瘤等重大疾病领域依然是院士聚集的高地。以周俭所在的肝癌领域为例， 全球每年新发肝癌病例约90万例，中国占比接近一半。 从此次新增院士名单来看，肿瘤等重大疾病领域依然是院士聚集的高地。 中国科学院、中国工程院11月21日公布2025年院士增选结果，分别选举产生中国科学院院士73人，中国 工程院院士71人。新当选的中国科学院院士中，生命科学和医学学部13人，来自上海的复旦大学附属中 山医院周俭和上海交大附属仁济医院房静远当选。 其他当选中国科学院院士的临床医学专家还包括浙江大学医学院附属邵逸夫医院蔡秀军、首都医科大学 附属北京天坛医院王拥军、中国医学科学院北京协和医院朱兰（女）。 周俭表示："这些成功经验有力证明，肝癌完全可以像高血压、糖尿病一样，被作为可防、可控、可治 的慢性病来管理。" 此外，周俭与樊嘉院士共同创建的miRNA肝癌早 ...